KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Operating Leases (2019 - 2026)

Idexx Laboratories has reported Operating Leases over the past 7 years, most recently at $101.2 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 3.39% year-over-year to $101.2 million; the TTM value through Dec 2025 reached $101.2 million, up 3.39%, while the annual FY2025 figure was $101.2 million, 3.39% up from the prior year.
  • Operating Leases for Q4 2025 was $101.2 million at Idexx Laboratories, down from $106.5 million in the prior quarter.
  • Over five years, Operating Leases peaked at $124.4 million in Q3 2024 and troughed at $78.2 million in Q1 2021.
  • A 5-year average of $105.2 million and a median of $104.7 million in 2024 define the central range for Operating Leases.
  • Biggest five-year swings in Operating Leases: skyrocketed 40.93% in 2022 and later dropped 14.38% in 2025.
  • Year by year, Operating Leases stood at $87.4 million in 2021, then increased by 15.86% to $101.2 million in 2022, then fell by 1.55% to $99.7 million in 2023, then dropped by 1.84% to $97.8 million in 2024, then increased by 3.39% to $101.2 million in 2025.
  • Business Quant data shows Operating Leases for IDXX at $101.2 million in Q4 2025, $106.5 million in Q3 2025, and $107.6 million in Q2 2025.